Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02610374 · ClinicalTrials.gov registry record · NA

Diet / Gut Microbiome Interaction and Influence on Inflammatory Disease in HIV Patients

A NA study of HIV, sponsored by University of Colorado, Denver.

Completed
Registry status
NA
Development phase
90
Enrollment target
1
Study location

NCT02610374 is a NA study of HIV that has completed, run by University of Colorado, Denver. The registered enrollment target is 90 participants, below the 440-participant average among 303 other HIV trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02610374, a NA study of HIV, has completed, sponsored by University of Colorado, Denver.

COMPLETED
Registry status
NA
Development phase
90 participants
Enrollment target
1
Study location

Study Summary

The primary objective is to assess the effect of short-term diet modification on the microbiome composition, and inflammatory/metabolic disease markers in Antiretroviral therapy (ART)-treated HIV-infected participants and Human immunodeficiency virus (HIV)-negative controls in the United States.

Conditions Studied

Interventions

  • OTHER Agrarian Diet
  • OTHER Western-type Diet

Study Locations (1)

Colorado

  • University of Colorado Denver - Aurora

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2016-03
Est. Completion 2020-03
Phase NA

Sponsor

University of Colorado, Denver

1,283 total trials

What the Registry Record Tells You About NCT02610374

The ClinicalTrials.gov registry entry for NCT02610374 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 440-participant average among 303 other HIV trials with a reported enrollment target (80% lower). The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with HIV appearing as the primary indexed condition, and to 2 interventions - of which Agrarian Diet is the first listed.

NCT02610374 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.

Frequently Asked Questions

What is clinical trial NCT02610374 about?

NCT02610374 is a clinical study titled "Diet / Gut Microbiome Interaction and Influence on Inflammatory Disease in HIV Patients". The primary objective is to assess the effect of short-term diet modification on the microbiome composition, and inflammatory/metabolic disease markers in Antiretroviral therapy (ART)-treated HIV-infected participants and Human immunodeficiency virus (HIV)-negative controls in the United States.

What is the current status of trial NCT02610374?

This trial is currently completed. It is a NA study. The enrollment target is 90 participants. The study started on 2016-03. Estimated completion is 2020-03.

What conditions does trial NCT02610374 study?

This clinical trial studies the following conditions: HIV.

What interventions are being tested in trial NCT02610374?

The interventions under investigation include: Agrarian Diet (OTHER), Western-type Diet (OTHER).

Who is sponsoring clinical trial NCT02610374?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02610374 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.